Skip to content

Home
Team
Portfolio
News
- TCG News
- Portfolio News
Careers
Contact

Menu

Home
Team
Portfolio
News
- TCG News
- Portfolio News
Careers
Contact

February 2019

Immune Design acquired by Merck for approx. $300M

Portfolio News / By admin

February 21, 2019

Kallyope Inc. Appoints Brett Lauring as Chief Medical Officer

Portfolio News / By admin

February 5, 2019

Search for:

Recent Posts

Carmot Therapeutics Enters into Definitive Merger Agreement with Roche
Neurona Therapeutics Presents New Clinical Data from First Cohort in Ongoing Phase I/II Open-Label Trial of NRTX-1001 Cell Therapy for Drug-resistant Mesial Temporal Lobe Epilepsy (MTLE)
Escient Pharamceuticals Initiates Clinical Proof-of-Concept Study of EP262, A First-in-Class Oral MRGPRX2 Antagonist, In Atopic Dermatitis
RAPT Therapeutics Announces Publication of Phase 1A/1B Clinical Trial of Zelnecirnon (RPT193) To Treat Atopic Dermatitis In Allergy
Carmot Therapeutics Commenced Phase 2 Clinical Trial of Novel Dual GLP-1/GIP Receptor Agonist CT-868 for the Treatment of Type 1 Diabetes

Recent Comments

Archives

Categories

Portfolio News
TCG News

The Column Group

Copyright © 2022. The Column Group | Privacy Policy | Terms of Use
Website developed by CP Communications

Scroll to Top